Marie Gronley
Psychiatry · Scottsdale, AZNPI 1447392725
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 278 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 27.9% of the total. Reporting peaked in 2022 at $1,775 and has fallen 76.6% since, to $415 in 2025. Among psychiatry clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 278 payments — averaging $27.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$783
- Johnson & Johnson$783
- Alkermes, Inc.$763
- Teva Pharmaceuticals USA, Inc.$692
- Corium, LLC$531
- plus $2K from 12 others
What the payments were for
- Food & beverage$7,23095%
- Education$3425%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 116 | $2,112 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $783 |
| Johnson & Johnson | 10 | $783 |
| Alkermes, Inc. | 25 | $763 |
| Teva Pharmaceuticals USA, Inc. | 17 | $692 |
| Corium, LLC | 15 | $531 |
| Bausch Health US, LLC | 19 | $415 |
| Vanda Pharmaceuticals Inc. | 11 | $313 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $271 |
| Otsuka America Pharmaceutical, Inc. | 3 | $242 |
| Supernus Pharmaceuticals, Inc. | 8 | $182 |
| Neurocrine Biosciences, Inc. | 1 | $127 |
| Sunovion Pharmaceuticals Inc. | 1 | $121 |
| Alfasigma USA, Inc. | 5 | $70 |
| Ironshore Pharmaceuticals Inc. | 2 | $58 |
| Shire North American Group Inc | 3 | $57 |
| Lundbeck LLC | 2 | $36 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,573 in reported general payments places this provider in the 90th percentile of 573 psychiatry providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $733 |
| Clonazepam | 25 | $603 |
| Oxcarbazepine | 16 | $275 |
| Zolpidem Tartrate | 11 | $261 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 22 | $140 |
| Quetiapine Fumarate | 14 | $126 |
| Escitalopram Oxalate | 17 | $120 |
| Alprazolam | 13 | $61 |
| Trazodone Hcl | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Scottsdale
- Henry SchulteScottsdale$77K
- Lauren BonnerScottsdale$44K
- Lois KrahnScottsdale$32K
- Alvin BursteinScottsdale$18K
- Alpa SanghviScottsdale$6K
- Adam KoelschScottsdale$5K
- Elizabeth RotellaScottsdale$4K
- Supriya NairScottsdale$4K
- Paul ValbuenaScottsdale$4K
- Jason CaplanPhoenix$999K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.